A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancerAlberto Chiappori, M. S. Berger, Marshall T. Schreeder et al.|British Journal of Cancer|2012Cited by 51
The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumorsLee S. Rosen, Niall C. Tebbutt, Sheryl McCoy et al.|BMC Cancer|2013Cited by 11
An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumorsRobert M. Jotte, Robert Ilaria, Daniel D. Von Hoff et al.|Investigational New Drugs|2014Cited by 10
A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL)John G. Gribben, Mark W. Frohlich, Nancy L. Bartlett et al.|Transplantation and Cellular Therapy|2005Cited by 1